Key Metrics
CiteScore 

2.7
H-Index 

19
SJR 

Q2Pharmacology (medical)

SNIP 

0.87
Recommended pre-submission checks
Powered by 

Topics Covered on Drugs - Real World Outcomes
Drugs - Real World Outcomes Journal Specifications
| Overview | |
| Publisher | SPRINGERNATURE |
| Language | English |
| Frequency | Quarterly |
| Article Processing Charges | EUR 2190 | USD 2690 | GBP 1890 |
| Publication Time | 8 |
| Editorial Review Process | Anonymous peer review |
| General Details | |
| Language | English |
| Frequency | Quarterly |
| Publication Start Year | 2014 |
| Publisher URL | Visit website |
| Website URL | Visit website |
| Publication Details | |
| Editorial Review Detail | |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| Deposit Policy | Sherpa/Romeo |
| License type | CC BY-NC |
| OA statement | Visit website |
View less
Planning to publish in Drugs - Real World Outcomes ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in Drugs - Real World Outcomes
Assessment of Potential Drug-Drug Interactions and Associated Factors Among Pulmonary Inpatients in a Tertiary Care Hospital: A Cross-Sectional Study.
- 25 Jun 2026
- Drugs - real world outcomes
Characteristics and Future Perspectives of Available Electronic Health Record Databases in Japan.
- 24 Jun 2026
- Drugs - real world outcomes
The Long-Term Sequelae and Clinical Workload Resulting from Toxicities of Immune Checkpoint Inhibitor (ICI) Therapy in Patients with Cancer.
- 23 Jun 2026
- Drugs - real world outcomes
Long-Term Antidepressant Use and Dementia Risk: A Propensity Score-Matched Study of Swiss Older Adults, with an Anticholinergic-Specific Analysis.
- 10 Jun 2026
- Drugs - real world outcomes
Real-World Evidence for Drug Value Assessment in China: Learning from International Experiences
- 4 Jun 2026
- Drugs - Real World Outcomes
Real-World Effectiveness and Safety of Ofatumumab in Relapsing Multiple Sclerosis: Comparison of Treatment-Na\xefve Patients and Switchers in a Multicenter Cohort
- 31 May 2026
- Drugs - Real World Outcomes
Assessment of Potential Drug-Drug Interactions and Associated Factors Among Pulmonary Inpatients in a Tertiary Care Hospital: A Cross-Sectional Study.
- 25 Jun 2026
- Drugs - real world outcomes
Characteristics and Future Perspectives of Available Electronic Health Record Databases in Japan.
- 24 Jun 2026
- Drugs - real world outcomes
The Long-Term Sequelae and Clinical Workload Resulting from Toxicities of Immune Checkpoint Inhibitor (ICI) Therapy in Patients with Cancer.
- 23 Jun 2026
- Drugs - real world outcomes
Long-Term Antidepressant Use and Dementia Risk: A Propensity Score-Matched Study of Swiss Older Adults, with an Anticholinergic-Specific Analysis.
- 10 Jun 2026
- Drugs - real world outcomes
Real-World Evidence for Drug Value Assessment in China: Learning from International Experiences
- 4 Jun 2026
- Drugs - Real World Outcomes
Real-World Effectiveness and Safety of Ofatumumab in Relapsing Multiple Sclerosis: Comparison of Treatment-Na\xefve Patients and Switchers in a Multicenter Cohort
- 31 May 2026
- Drugs - Real World Outcomes